glp 1 drug liraglutide may protect against dementia GLP-1 brain from AD First Generic GLP-1 Injection OK'd

B.DragojeviT.Vidal-RosasE

An RDP study with 40 patients investigated the effects of 300 mg Pycnogenol supplementation per day for two months on subjects with chronic venous insufficiency (CVI) ( significantly relieved swelling (64%) and heaviness (54%) in the legs of CVI patients compared to placebo (7 and 3%, respectively)

Rinse thoroughly and pat dry

A minimal model was used for analyses in which there were insufficient numbers of eligible patients to allow use of the full model (see Exploratory Analyses: Impact of Baseline BMI, Demaglutide Dose, Previous Treatment, Sex and Age)

Glucagon-like peptide-1 receptor (GLP-1R) agonists have emerged as therapeutic agents for obesity in adults and have shown benefits outside of weight loss

Alzheimers disease: The alternative serotonergic hypothesis of cognitive decline